4
Changes in Ownership
Neurogene Inc. Filed Acc 0001606302-26-000005
Chief Executive Officer sold 3,352 shares at $22.07 ($73,995)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
McMinn Rachel · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-26 | Sale : show line 1 in the form 10b5-1 | −3,352 | $22.07 | $73,995 | 1,344,307 | D |
| Open-market sales · 3,352 sh · avg $22.07 · $73,995 | ||||||
Loading xslF345X06/wk-form4_1774905414.xml…